SecBot SecBot
SECBOTREPLAY Home › Report › SLNO

SLNO · Analysis based on filing metadata only, document content was…

SOLENO THERAPEUTICS INC · CLUSTER filed Mar 26, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 26, 2026 at 20:00 ET

Analysis based on filing metadata only, document content was unavailable. Two insiders at Soleno Therapeutics Inc. (SLNO) conducted open-market sales totaling approximately $274K within the last 7 days, representing a small fraction of the company's $1.6B market cap.

  • Filing is an insider trading cluster involving two executives at SLNO.
  • Chief Commercial Officer and Senior VP of Clinical Development each sold shares in late March 2026.
  • Total open-market sales amount to ~$274K, or 0.017% of SLNO's $1.6B market cap.
  • No document content available to assess context or motivation behind trades.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access